Vincenzo Facchini

820 total citations
19 papers, 671 citations indexed

About

Vincenzo Facchini is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Vincenzo Facchini has authored 19 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Pharmacology and 3 papers in Physiology. Recurrent topics in Vincenzo Facchini's work include Pharmacogenetics and Drug Metabolism (4 papers), Alkaloids: synthesis and pharmacology (3 papers) and Receptor Mechanisms and Signaling (3 papers). Vincenzo Facchini is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Alkaloids: synthesis and pharmacology (3 papers) and Receptor Mechanisms and Signaling (3 papers). Vincenzo Facchini collaborates with scholars based in United Kingdom, Belgium and United States. Vincenzo Facchini's co-authors include Róbert Kiss, Florence Lefranc, Tatjana Mijatovic, John A. Timbrell, L. A. Griffiths, Laurent Ingrassia, Francis Darro, Anne Mathieu, Eric Van Quaquebeke and Bo Nilsson and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Chromatography A and Biochemical Pharmacology.

In The Last Decade

Vincenzo Facchini

19 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vincenzo Facchini United Kingdom 12 394 106 84 77 76 19 671
Beiying Qiu Singapore 17 549 1.4× 82 0.8× 45 0.5× 82 1.1× 74 1.0× 32 883
Songpei Li China 18 420 1.1× 116 1.1× 56 0.7× 69 0.9× 69 0.9× 29 754
Tianxin Yang China 21 671 1.7× 141 1.3× 79 0.9× 120 1.6× 170 2.2× 30 1.2k
Peter J. Bungay United Kingdom 18 428 1.1× 47 0.4× 83 1.0× 64 0.8× 103 1.4× 35 948
Sylvie Bardon France 16 478 1.2× 116 1.1× 34 0.4× 157 2.0× 220 2.9× 22 1.1k
Yuan Gu China 17 487 1.2× 35 0.3× 81 1.0× 121 1.6× 97 1.3× 58 886
Aamer Qazi United States 19 521 1.3× 61 0.6× 54 0.6× 192 2.5× 146 1.9× 31 1000
Narçın Palavan-Ünsal Türkiye 19 723 1.8× 140 1.3× 28 0.3× 136 1.8× 120 1.6× 65 1.1k
Li‐Xing Feng China 16 579 1.5× 114 1.1× 66 0.8× 122 1.6× 90 1.2× 30 854

Countries citing papers authored by Vincenzo Facchini

Since Specialization
Citations

This map shows the geographic impact of Vincenzo Facchini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincenzo Facchini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincenzo Facchini more than expected).

Fields of papers citing papers by Vincenzo Facchini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincenzo Facchini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincenzo Facchini. The network helps show where Vincenzo Facchini may publish in the future.

Co-authorship network of co-authors of Vincenzo Facchini

This figure shows the co-authorship network connecting the top 25 collaborators of Vincenzo Facchini. A scholar is included among the top collaborators of Vincenzo Facchini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincenzo Facchini. Vincenzo Facchini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Mijatovic, Tatjana, Laurent Ingrassia, Vincenzo Facchini, & Róbert Kiss. (2008). Na+/K+-ATPase α subunits as new targets in anticancer therapy. Expert Opinion on Therapeutic Targets. 12(11). 1403–1417. 67 indexed citations
2.
Mijatovic, Tatjana, Nancy De Nève, Philippe Gailly, et al.. (2008). Nucleolus and c-Myc: potential targets of cardenolide-mediated antitumor activity. Molecular Cancer Therapeutics. 7(5). 1285–1296. 57 indexed citations
3.
Mijatovic, Tatjana, I. Roland, Eric Van Quaquebeke, et al.. (2007). The α1 subunit of the sodium pump could represent a novel target to combat non‐small cell lung cancers. The Journal of Pathology. 212(2). 170–179. 139 indexed citations
4.
Lefranc, Florence, Vincenzo Facchini, & Róbert Kiss. (2007). Proautophagic Drugs: A Novel Means to Combat Apoptosis-Resistant Cancers, with a Special Emphasis on Glioblastomas. The Oncologist. 12(12). 1395–1403. 211 indexed citations
5.
Astles, Peter C., Clive Brealey, Thomas J. Brown, et al.. (1998). Selective Endothelin A Receptor Antagonists. 3. Discovery and Structure−Activity Relationships of a Series of 4-Phenoxybutanoic Acid Derivatives. Journal of Medicinal Chemistry. 41(15). 2732–2744. 16 indexed citations
6.
Bush, Raymond C., et al.. (1996). RP 64477: A potent inhibitor of acyl-coenzyme A. Biochemical Pharmacology. 51(4). 413–421. 5 indexed citations
7.
Smith, Christopher, Michael J. Ashton, Raymond C. Bush, et al.. (1996). RP 73163: A bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor. Bioorganic & Medicinal Chemistry Letters. 6(1). 47–50. 11 indexed citations
8.
9.
Timbrell, John A., et al.. (1984). Hydralazine-induced lupus: is there a toxic metabolic pathway?. European Journal of Clinical Pharmacology. 27(5). 555–559. 19 indexed citations
10.
Facchini, Vincenzo & L. A. Griffiths. (1981). The involvement of the gastro-intestinal microflora in nitro-compound-induced methaemoglobinaemia in rats and its relationship to nitrogroup reduction. Biochemical Pharmacology. 30(9). 931–935. 29 indexed citations
11.
Facchinetti, Fabio, et al.. (1981). PROOPIOCORTIN-RELATED PEPTIDES IN AGING. IRIS UNIMORE (University of Modena and Reggio Emilia). 243. 35–35. 4 indexed citations
12.
Timbrell, John A., et al.. (1981). Effect of dose on acetylator phenotype distribution of hydralazine. Clinical Pharmacology & Therapeutics. 29(3). 337–343. 9 indexed citations
13.
Facchini, Vincenzo, et al.. (1981). Further evidence for an acetylator phenotype difference in the metabolism of hydralazine in man.. British Journal of Clinical Pharmacology. 11(4). 345–351. 15 indexed citations
14.
Harland, S. J., Vincenzo Facchini, & John A. Timbrell. (1980). Hydrallazine-induced lupus erythematosus-like syndrome in a patient of the rapid acetylator phenotype.. BMJ. 281(6235). 273.2–274. 17 indexed citations
15.
Facchini, Vincenzo & John A. Timbrell. (1980). Determination of hydralazine metabolites: 4-hydrazinophthalazin-1-one and n-acetylhydrazinophthalazin-1-one by gas chromatography and s-triazolo[3,4-a]phthalazine and phthalazinone by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 183(2). 167–173. 6 indexed citations
16.
Facchini, Vincenzo & L. A. Griffiths. (1980). The metabolic fate of nitromide in the rat. I. Metabolism and excretion. Xenobiotica. 10(4). 289–297. 5 indexed citations
17.
Timbrell, John A., et al.. (1980). Polymorphic acetylation of hydralazine. Clinical Pharmacology & Therapeutics. 28(3). 350–355. 40 indexed citations
18.
Facchini, Vincenzo, Anthony J. Streeter, & John A. Timbrell. (1980). Determination of hydralazine and its acetylated metabolites in urine by gas chromatography and high-pressure liquid chromatography. Journal of Chromatography A. 187(1). 218–223. 13 indexed citations
19.
Facchini, Vincenzo & L. A. Griffiths. (1980). Metabolism of nitromide in the rat. II. Sites of nitro-reduction. Xenobiotica. 10(4). 299–305. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beiying Qiu Breakdown of academic impact, for papers by Songpei Li Breakdown of academic impact, for papers by Tianxin Yang Breakdown of academic impact, for papers by Peter J. Bungay Breakdown of academic impact, for papers by Sylvie Bardon Breakdown of academic impact, for papers by Yuan Gu Breakdown of academic impact, for papers by Aamer Qazi Breakdown of academic impact, for papers by Narçın Palavan-Ünsal Breakdown of academic impact, for papers by Li‐Xing Feng
Rankless by CCL
2026